Clinical Trials Browser

Phase 2/3 × Hepatoblastoma × Gastrointestinal × Clear all

NCT05322187 2022-04-11

sPLENTY-pc

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

NCT03728543 2018-11-02

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Phase 2/3 Unknown

Gastrointestinal

Neoplasms, beta-Thalassemia, Hepatoblastoma